Study guide
2.1 Family History, Pedigree Construction & Analysis
Certified Genetic Counselor CGC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the CGC Exam & Credential 1.2 Eligibility Categories, Application & Fees 1.3 Scoring, Pass Rate & Test-Day Logistics
2 Domain 1A: Clinical Information
1.4 Medical & Pregnancy History 1.5 Teratogens, Exposures & Non-Genetic Risk Factors 1.6 Differential Diagnosis, Indication & Referral Urgency 1.7 Referral Triage, Case Preparation & Records Review
3 Domain 1B: Human Development
1.8 Fetal Development 1.9 Developmental Milestones 1.10 Physical & Psychological Development
4 Domain 1C: Chromosomal & Contiguous Gene Syndromes
1.11 Aneuploidy Syndromes (Down, Turner, Klinefelter, Edwards, Patau) 1.12 Microdeletion Syndromes (22q11.2, Williams, and Related) 1.13 Imprinting Disorders (PWS, Angelman, Beckwith-Wiedemann, Russell-Silver)
5 Domain 1C: Hereditary Cancer Syndromes
1.14 Hereditary Breast & Ovarian Cancer (BRCA1/2, PALB2, and Related) 1.15 Lynch Syndrome & Polyposis Syndromes 1.16 Li-Fraumeni, VHL, MEN, NF1/NF2 & Other Cancer Predisposition
6 Domain 1C: Metabolic, Neuromuscular & Multisystem Conditions
1.17 Inborn Errors of Metabolism & Storage Disorders 1.18 Neuromuscular Disease & Fragile X Spectrum 1.19 Connective Tissue & Cardiovascular Genetics 1.20 Screening, Surveillance, Treatment & Diagnostic Strategy Framework
7 Domain 2A: Pedigree & Risk Assessment
2.1 Family History, Pedigree Construction & Analysis 2.2 Mendelian Risk Calculations 2.3 Bayesian Risk Calculations 2.4 Empiric Risk, Multifactorial Recurrence & Risk-Assessment Models 2.5 Residual Risk & Follow-Up Medical Plans
8 Domain 2B: Inheritance Principles
2.6 Mendelian Inheritance Patterns 2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial) 2.8 Penetrance, Expressivity, Anticipation & Heterogeneity 2.9 Mosaicism, X-Inactivation & Epigenetic Modifiers of Phenotype
9 Domain 2B: Population Genetics & Variation
2.10 Population Genetics, HWE & Quantitative Genetics 2.11 Human Genetic Variation & Disease Susceptibility
10 Domain 3A: Test Methodologies
3.1 Karyotype, FISH & Chromosomal Microarray 3.2 Molecular Diagnostics (Sanger, NGS Panels, WES, WGS, MLPA) 3.3 Sample Types, Clinical Context & Predictive Metrics
11 Domain 3A: Variant Interpretation
3.4 ACMG/AMP Variant Classification 3.5 Reanalysis, Reclassification & Validity/Utility Framework
12 Domain 3B: Testing Options
3.6 Diagnostic Testing Strategies 3.7 Screening Testing (including Newborn Screening) 3.8 Predictive & Pre-symptomatic Testing 3.9 Carrier, Somatic & Research Testing
13 Domain 3C: Reproductive Risk Management
3.10 Assisted Reproductive Technologies & PGT 3.11 Family Planning & Reproductive Options 3.12 Prenatal Screening (NIPT, Serum Markers) 3.13 Prenatal Diagnostic Procedures (CVS, Amniocentesis)
14 Domain 4A: Counseling Foundations
4.1 Contracting & Interviewing Techniques 4.2 Psychosocial Assessment, Follow-Up & Family Dynamics 4.3 Client Personal Identity & Cultural Humility
15 Domain 4A: Theories, Coping & Dynamics
4.4 Counseling Theories & Models (REM, Trajectory) 4.5 Defense Mechanisms, Coping & Decision-Making Styles 4.6 Grief, Perinatal Loss & Crisis Response 4.7 Self-Awareness & Client-Counselor Dynamics
16 Domain 4B: Communication & Education
4.8 Delivery Modes & Working with Interpreters 4.9 Risk Communication Theories & Models 4.10 Results Delivery & Long-Term Follow-Up 4.11 Health Literacy, Informed Consent & Informed Decision Making
17 Domain 5A–B: Finance & Client Resources
5.1 Insurance Policies, Billing & Letters of Medical Necessity 5.2 Billing, Coding & Reimbursement Compliance 5.3 Client Resources, Appropriateness & Timely Delivery
18 Domain 5C: Legal & Regulatory Requirements
5.4 GINA & Genetic Non-Discrimination Legislation 5.5 Privacy, Confidentiality, Documentation & Genomic Data Security 5.6 Human-Subjects Research Standards & Patient Access to Information 5.7 CLIA, Laboratory-Developed Tests & FDA Oversight 5.8 Genomic Data Security, DTC Testing & Data Sharing
19 Domain 5D: Professional Frameworks
5.9 NSGC Code of Ethics & Ethical Decision Making 5.10 Scope of Practice, Clinical Supervision & Conflict of Interest 5.11 Licensure, Credentialing & Maintaining the CGC Credential 5.12 Evidence-Based Practice & Professional/Public Education
20 Integration & Exam Strategy
6.1 Integrating Domains in Case-Based Practice & Exam Strategy
2.1 Family History, Pedigree Construction & Analysis
Key Takeaways Explain This Topic AI
Standard pedigree symbols encode sex, status (affected/unaffected/carrier/deceased), relationship lines, consanguinity, adoption, twins, and unknown information so inheritance patterns can be read at a glance
Autosomal dominant pedigrees show vertical transmission and male-to-male transmission; autosomal recessive pedigrees often show horizontal sibship clustering, especially with consanguinity
X-linked patterns lack male-to-male transmission; mitochondrial pedigrees transmit only through females to all children, with males not transmitting further
A three-generation pedigree with ethnicity, ages/ages at diagnosis, and negative findings is the minimum intake product for CGC risk assessment
Pattern recognition drives differential diagnosis and testing strategy; incomplete penetrance and phenocopies can mimic or mask classic Mendelian patterns
Last updated: August 2026
2.1 Family History, Pedigree Construction & Analysis
Quick Answer: Construct a three-generation (or more) pedigree using standardized symbols for sex, affection status, relationships, consanguinity, adoption, twins, and unknowns. Read the pedigree for AD, AR, XL, and mitochondrial patterns, then reconcile incomplete penetrance, variable expressivity, and phenocopies before assigning risk.
Domain 2A items test whether you can turn a messy family story into a usable pedigree and recognize inheritance patterns that change carrier risk, testing strategy, and residual risk counseling.
Why Pedigree Skills Matter on the CGC Exam
Nearly every risk vignette starts with family history. Exam stems may give a drawn pedigree, a verbal history, or both. Your tasks are to (1) encode the history correctly, (2) identify the most likely inheritance pattern, (3) spot red flags that weaken a classic pattern (non-paternity assumptions, adoption, limited family size, early deaths without diagnoses), and (4) use the pedigree to choose who to test first and how to counsel relatives.
A pedigree is not decorative. It is the primary risk-assessment worksheet for Mendelian and Bayesian calculations in later sections of this chapter.
Intake → Pedigree Workflow
Collect at least three generations centered on the consultand (the person seeking counseling). Include:
- Ages or year of birth; ages at diagnosis and death when relevant
- Specific diagnoses (not only "cancer" or "heart problem")
- Negative findings ("no one else with hearing loss") — negatives change Bayesian calculations
- Ancestry/ethnicity for carrier-frequency priors
- Consanguinity, donor gametes, adoption, half-sibs, multiple partners
- Pregnancy losses, terminations, and infertility when relevant to the indication
Document who provided the history and flag unverified diagnoses. When a relative's diagnosis drives risk (for example, pathologically confirmed colon cancer at 35), note verification status.
Standard Symbols and Relationship Lines
Use conventional genetic counseling pedigree nomenclature (NSGC-style / Bennett et al. conventions commonly taught for board exams):
Element Standard representation Counseling note
Male / female / unknown sex Square / circle / diamond Prefer sex recorded at birth or self-identified sex per clinic policy; exam stems usually use binary symbols
Consultand Arrow pointing to the individual The consultand is not always the proband
Proband Arrow (often with "P") identifying the affected person who brought the family to medical attention May differ from the person in session
Affected Filled symbol Shade by phenotype key when multiple traits
Carrier (autosomal / X-linked) Dot in center (or half-shaded per legend) Distinguish obligate vs. possible carrier in the key
- Deceased Diagonal slash through symbol Record age and cause when known
- Pregnancy "P" or diamond/triangle conventions per key Annotate gestational age and outcome
- No offspring by choice / infertility Hash mark or annotated "no issue" Do not confuse with unknown
- Relationship line Horizontal line between partners Multiple partners = multiple lines or numbered unions
- Sibship line Vertical drop to a horizontal sibship bar Order left-to-right by birth when known
- Consanguinity Double relationship line Critical for AR risk elevation
Adoption Brackets around adoptee; dashed line to adoptive parents; solid to biologic when known Clarify biologic vs. social risk
Twins Converging lines from sibship bar; monozygotic often with a bar between twins Ask zygosity; unknown zygosity affects some risks
Unknown / limited information "?" annotation or open symbol with note Do not invent affection status
Relationship pitfalls: half-siblings share one parent; step-relatives without shared biology do not contribute Mendelian risk; donor-conceived children require a separate biologic pedigree when the indication is heritable disease.
Pattern Recognition: AD, AR, XL, Mitochondrial
Pattern Classic pedigree clues High-yield exceptions
Autosomal dominant (AD) Vertical transmission; both sexes affected; male-to-male transmission present Incomplete penetrance creates "skipped" generations; de novo variants in the proband; mosaicism
Autosomal recessive (AR) Horizontal clustering in sibs; parents usually unaffected; consanguinity raises suspicion Small families may show only one affected child; pseudodominance in high-carrier populations
X-linked (XL) No male-to-male transmission; more severe/affected males; carrier females may be mildly affected Skewed X-inactivation; germline mosaicism; de novo variants in mothers of isolated cases
Mitochondrial Transmission only through females to sons and daughters; males do not transmit the mtDNA variant Heteroplasmy causes variable severity; nuclear gene mimics exist
Worked Pattern Reads
AD example: A grandfather, father, and son all have neurofibromas and café-au-lait macules. Male-to-male transmission rules out XL and mitochondrial inheritance for that phenotype and strongly supports AD (for example, NF1).
AR example: Two sisters with cystic fibrosis; parents healthy; parents are first cousins. Horizontal sibship plus consanguinity supports AR. Each parent is an obligate carrier if the children's diagnoses are confirmed and truly AR.
XL example: Multiple males related through females have Duchenne muscular dystrophy; no father-to-son transmission. An unaffected sister of an affected boy has a prior carrier risk that Bayesian analysis will refine (Section 2.3).
Mitochondrial example: A mother and all of her children show sensorineural hearing loss and maternal relatives are similarly affected; the father's lineage is clear. Mitochondrial inheritance is on the differential, but confirm that a nuclear AD mimic is not equally plausible.
Analytic Traps That Change Risk
Incomplete penetrance: An unaffected parent with an affected child and affected grandparent does not automatically exclude AD.
Variable expressivity: Mild findings in "unaffected" relatives may reclassify the pedigree.
Phenocopies: Sporadic disease in a relative can falsely suggest transmission.
Misattributed parentage: Silent assumption of biologic relationships can break an XL or AD narrative.
Limited family structure: Few males in an XL pedigree underpowers pattern recognition.
Assisted reproduction / adoption: Social pedigree ≠ biologic risk pedigree.
Exam Scenario Mindset
When a stem shows a pedigree and asks "most likely inheritance," eliminate patterns that violate hard rules first (male-to-male transmission eliminates XL and mtDNA). Then weigh penetrance, sex distribution, and consanguinity. When asked what information is missing, prioritize ethnicity, ages at onset, pathologic confirmation, and relationship biology.
Connecting Pedigree to Downstream Risk Work
Once the pattern is proposed:
Identify obligate carriers and consultand position in the pedigree.
Assign simple Mendelian priors (Section 2.2).
Incorporate negative tests, normal exams, or age-related unaffected status via Bayes (Section 2.3).
Translate residual probability into follow-up testing and medical plans (Section 2.5).
Pedigree construction quality determines whether those later calculations are even pointed at the right person.